Alterity Therapeutics (PRNAD) Return on Capital Employed (2010 - 2019)

Alterity Therapeutics (PRNAD) has reported Return on Capital Employed for 4 consecutive years, with 136.03% the latest figure, recorded in Q4 2019.

• In Q4 2019, Return on Capital Employed fell 13599.0% year-over-year to 136.03%; the TTM figure through Dec 2019 stood at 136.03% (down 13599.0% YoY), while the FY2023 annual figure was 43.17%, down 341.0% from the prior year.
• Return on Capital Employed came in at 136.03% for Q4 2019 at Alterity Therapeutics, down from 0.04% in the prior quarter.
• The five-year high for Return on Capital Employed was 0.04% in Q4 2018, with the low at 136.03% in Q4 2019.
• Average Return on Capital Employed over 4 years is 34.06%, with a median of 0.08% recorded in 2016.
• Across the five-year window, Return on Capital Employed advanced 4 bps in 2018 and slumped 13599 bps in 2019, its largest moves.
• Year by year, Return on Capital Employed stood at 0.09% in 2016, then advanced by 9 bps to 0.08% in 2017, then soared by 46 bps to 0.04% in 2018, then plunged by 315094 bps to 136.03% in 2019.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 136.03%, 0.04%, and 0.08% for Q4 2019, Q4 2018, and Q4 2017 respectively.